We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MIAX:NYSEMiami International Holdings, Inc. Analysis

Data as of 2026-04-17 - not real-time

$44.85

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Miami International Holdings (MIAX) is trading at $44.85, well above its DCF fair value of roughly $19.6 and the forward P/E of 25.99 versus an industry average of 17.55, indicating a significant premium. Technical indicators show a bullish MACD crossover but an RSI hovering near 70, suggesting the stock is overbought, while volume is on a decreasing trend and the 20‑day SMA sits just below the current price, reinforcing a short‑term bearish bias. Price action is flirting with the calculated resistance around $45, with support near $37, limiting upside potential in the near term.
On the fundamentals side, MIAX posted a 14% revenue growth year‑over‑year and captured a record 18.2% share of the multi‑listed options market in Q4 2025, highlighting strong product momentum. The company’s cash position (~$478M) comfortably exceeds its modest debt load, yet profitability remains a challenge with a negative profit margin and a -11% ROE. While the firm operates in a low‑beta (0.68) environment, its 30‑day volatility exceeds 30%, and the capital‑markets sector carries medium regulatory exposure. Overall, the stock appears overvalued in the short run, but its growth trajectory and market‑share gains provide a rationale for a more neutral to cautiously optimistic stance over longer horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI approaching overbought territory
  • Price near resistance with decreasing volume
  • Technical trend flagged as bearish

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and record market‑share gains
  • Robust cash balance offsetting modest debt
  • Valuation premium still present but upside potential of ~8% per DCF

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Continued expansion in multi‑asset exchange offerings
  • Technology‑driven platform positioning for industry consolidation
  • Potential for improved profitability as scale increases

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin-5.13%
P/E Ratio26.0
ROE-11.22%
ROA6.16%
Debt/Equity2.81
P/B Ratio4.4
Op. Cash Flow$167.8M
Free Cash Flow$55.7M
Industry P/E17.5

Technical Analysis

TrendBearish
RSI69.9
Support$37.10
Resistance$44.99
MA 20$40.50
MA 50$40.71
MA 200$41.64
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Fair Value$19.56
Target Price$48.40
Upside/Downside7.92%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.68
Volatility32.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.